A Clinical Study to Compare Jatamansi and Sarpagandha Ayurvedic Herbal Powders Given Under the Tongue in Primary Insomnia

A comparative clinical study to evaluate the efficacy of sublingual administration of churnakriya nirmit jatamansi churna and sarpagandha churna in the management of anidra w.s.r. to primary insomnia: an open-label randomized trial - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100632

Enrollment

Registered

2026-01-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F510- Insomnia not due to a substance orknown physiological condition

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age between 18 to 70 years of either gender 2 Primary Insomnia like Insomnia without Identifiable Cause and Psycho physiologic Insomnia 3 If the complaint is Jrimbha Tandra Angmard Shiro Gaurav Jadya Glani Bhrama and Apakti 4 Insomnia Severity Index ISI score greater than 7 5 A Global Pittsburgh Sleep Quality Index PSQI score greater than 5 6 Willing to come for regular follow up

Exclusion criteria

Exclusion criteria: 1 Patients below 18 and above 70 years of age 2 Patients suffering from chronic Insomnia who were addicted to sedative medications and taking any drugs possessing sedative effect will be excluded also patients of Rajyakshma Unmada or Apsmara 3 Secondary Insomnia like Transient Situational Insomnia also Insomnia Associated with Neurological Disorders Mental Disorders Drug or Alcohol Dependent Insomnia 4 Patient with systemic uncontrolled disease like type I or II diabetes hypertension hypotension etc 5 Pregnant or lactating women

Design outcomes

Secondary

Measure	Time frame
1 To assess the improvement in sleep onset maintenance & quality 2 To evaluate the overall impact on physical & mental wellbeing with respect to Insomnia Severity Index ISI & Pittsburgh Sleep Quality Index PSQI 3 To compare the safety & tolerability of both drugsTimepoint: Baseline & Day 30	—

Primary

Measure	Time frame
To evaluate and compare the efficacy of sublingual administration of churnakriya nirmit Jatamansi Churna and Sarpagandha Churna in the management of AnidraTimepoint: Baseline and Day 30	—

Countries

India

Contacts

Public ContactDr Yukta J Kapadia

Shree Swaminarayan Ayurvedic College Kalol

pravinkharadi321@gmail.com9978136650

Outcome results